Document is current

Article History

Received: 5 May 2023

Accepted: 11 October 2023

First Online: 16 November 2023

Declarations

:

: Not applicable.

: Not applicable.

: RJM reports research support and honoraria from Abbott, American Regent, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim/Eli Lilly and Company, Boston Scientific, Cytokinetics, Fast BioMedical, Gilead Sciences, Innolife, Medtronic, Merck, Novartis, Relypsa, Respicardia, Roche, Sanofi, Vifor, and Windtree Therapeutics and is Chair of the Council on the Kidney in Cardiovascular Disease, American Heart Association. SAB reports serving on the advisory board and speaker bureau for AstraZeneca, Boehringer Ingelheim/Eli Lilly and Company, and NovoNordisk and is on the on the advisory board for Abbott Diabetes Care. JR reports consultancy agreements with AstraZeneca, Boehringer Ingelheim/Eli Lilly and Company, and Edwards Lifesciences and serves on the medical advisory board of Procyrion Inc. (Aortix™)